Type of Spiritual Experience
A description of the experience
Tacrine is a centrally acting anticholinesterase and indirect cholinergic agonist (parasympathomimetic). It was the first centrally acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease, and was marketed under the trade name Cognex. It also acts as a histamine N-methyltransferase inhibitor
On Oct, 20, 2015: 733 people reported to have side effects when taking Cognex. Among them, 44 people (6.00%) have Hallucination.
On Sep, 30, 2015: 733 people reported to have side effects when taking Cognex. Among them, 3 people (0.41%) have Death.
The source of the experienceeHealthme
Concepts, symbols and science items
Activities and commonsteps
SuppressionsAcetylcholine and its ligands
Dementia and Alzheimers